As of March 23, 2026, Capricor Therapeutics's top three insider holders are Shinyaku Co Ltd Nippon (TenPercentOwner, 7.09Mn shares), Linda Marban (Chief Executive Officer, 211.10K shares), Frank Litvack (Director, 129.84K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Shinyaku Co Ltd Nippon | 7,090,351 | 0 | 24 Sep, 2024 | |
| Linda Marban | Chief Executive Officer | 211,104 | 0 | 05 Mar, 2025 |
| Frank Litvack | 129,839 | 0 | 04 Mar, 2025 | |
| David B Musket | 81,692 | 0 | 09 Aug, 2024 | |
| Louis Manzo | 62,147 | 0 | 23 Feb, 2023 | |
| Earl M Jr Collier | 57,606 | 0 | 28 Feb, 2025 | |
| Frank Litvack | 0 | 46,278 | 04 Dec, 2024 | |
| Karen Krasney | Evp, General Counsel | 28,047 | 0 | 16 Dec, 2024 |
| George W Jr Dunbar | 14,306 | 0 | 23 Dec, 2025 | |
| Anthony Bergmann | Chief Financial Officer | 8,223 | 0 | 04 Mar, 2025 |
| Paul Gisbert Auwaerter | 5,000 | 0 | 10 Oct, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 05 Jan, 2026 | Anthony Bergmann | Stock Option (Right to Buy) | A | 25,000 | $0.00 | 25,000 | D | A |
| 05 Jan, 2026 | Frank Litvack | Stock Option (Right to Buy) | A | 50,000 | $0.00 | 50,000 | D | A |
| 05 Jan, 2026 | Karimah Es Sabar | Stock Option (Right to Buy) | A | 15,500 | $0.00 | 15,500 | D | A |
| 05 Jan, 2026 | Mike Kelliher | Stock Option (Right to Buy) | A | 15,500 | $0.00 | 15,500 | D | A |
| 05 Jan, 2026 | Philip J Gotwals | Stock Option (Right to Buy) | A | 15,500 | $0.00 | 15,500 | D | A |
| 05 Jan, 2026 | Linda Marban | Stock Option (Right to Buy) | A | 50,000 | $0.00 | 50,000 | D | A |
| 05 Jan, 2026 | Paul Gisbert Auwaerter | Stock Option (Right to Buy) | A | 15,500 | $0.00 | 15,500 | D | A |
| 05 Jan, 2026 | Karen Krasney | Stock Option (Right to Buy) | A | 22,500 | $0.00 | 22,500 | D | A |
| 05 Jan, 2026 | George W Jr Dunbar | Stock Option (Right to Buy) | A | 15,500 | $0.00 | 15,500 | D | A |
| 05 Jan, 2026 | David B Musket | Stock Option (Right to Buy) | A | 15,500 | $0.00 | 15,500 | D | A |
| 05 Jan, 2026 | Linda Marban | Stock Option (Right to Buy) | A | 100,000 | $0.00 | 100,000 | D | A |
| 05 Jan, 2026 | Paul Gisbert Auwaerter | Stock Option (Right to Buy) | A | 1,360 | $0.00 | 1,360 | D | A |
| 05 Jan, 2026 | Anthony Bergmann | Stock Option (Right to Buy) | A | 25,000 | $0.00 | 25,000 | D | A |
| 05 Jan, 2026 | Karen Krasney | Stock Option (Right to Buy) | A | 22,500 | $0.00 | 22,500 | D | A |
| 05 Jan, 2026 | Anthony Bergmann | Restricted Stock Units | A | 2,500 | $0.00 | 2,500 | D | A |
| 05 Jan, 2026 | Linda Marban | Restricted Stock Units | A | 7,500 | $0.00 | 7,500 | D | A |
| 05 Jan, 2026 | Paul Gisbert Auwaerter | Stock Option (Right to Buy) | A | 5,420 | $0.00 | 5,420 | D | A |
| 19 Dec, 2025 | George W Jr Dunbar | Common Stock | A | 3,000 | $1.39 | 14,306 | D | M |
| 19 Dec, 2025 | George W Jr Dunbar | Stock Option (Right to Buy) | D | 3,000 | $0.00 | 0 | D | M |
| 03 Mar, 2025 | Linda Marban | Common Stock | A | 25,000 | $1.39 | 223,604 | D | M |